Source:http://linkedlifedata.com/resource/pubmed/id/18367662
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0002006,
umls-concept:C0007634,
umls-concept:C0016030,
umls-concept:C0022646,
umls-concept:C0030190,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0243125,
umls-concept:C0331858,
umls-concept:C0442805,
umls-concept:C0547047,
umls-concept:C0699900,
umls-concept:C1704256,
umls-concept:C1704640,
umls-concept:C1706515
|
pubmed:issue |
6
|
pubmed:dateCreated |
2008-6-6
|
pubmed:abstractText |
Aldosterone is thought to modulate renal fibrosis, in part, through increasing plasminogen activator inhibitor type 1 (PAI-1), a major inhibitor of ECM degradation. The present study investigated aldosterone effects on PAI-1 and transforming growth factor (TGF)-beta(1) and asked whether PAI-1 effects were TGF-beta mediated and whether aldosterone and TGF-beta(1) acted synergistically to increase PAI-1 and decrease ECM degradation. Rat mesangial cells (MCs) and fibroblast cells [normal rat kidney (NRK)-49F] were used. (3)H-labeled ECM was produced by MCs. The effect of aldosterone and TGF-beta on ECM degradation by newly plated MCs or NRK-49F was measured by the release of (3)H into medium. Aldosterone markedly increased PAI-1 mRNA and protein in both cell types, increases completely blocked by spironolactone and partially blocked by TGF-beta neutralizing antibody. Adding both aldosterone and TGF-beta(1) produced PAI-1 mRNA and protein increases higher than the sum of increases seen with either compound alone. Aldosterone or TGF-beta(1) alone inhibited matrix degradation by 39 and 49% in MCs and 21 and 23% in NRK-49F, respectively. When both compounds were added, matrix degradation was further decreased by 93% in MCs and 61% in NRK-49F. The results indicate that aldosterone-induced PAI-1 increases are partially mediated by TGF-beta(1) and lead to decreased ECM degradation. While aldosterone alone induced TGF-beta(1) weakly, aldosterone and TGF-beta(1) added together produced dramatic synergistic effects on PAI-1 production and subsequent ECM accumulation. Thus the elevated aldosterone induced by renin-angiotensin-aldosterone system activation may amplify renin-angiotensin-aldosterone system profibrotic actions.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1931-857X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
294
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
F1287-95
|
pubmed:dateRevised |
2011-4-28
|
pubmed:meshHeading |
pubmed-meshheading:18367662-Aldosterone,
pubmed-meshheading:18367662-Animals,
pubmed-meshheading:18367662-Cells, Cultured,
pubmed-meshheading:18367662-Drug Synergism,
pubmed-meshheading:18367662-Extracellular Matrix,
pubmed-meshheading:18367662-Fibroblasts,
pubmed-meshheading:18367662-Fibrosis,
pubmed-meshheading:18367662-Gene Expression,
pubmed-meshheading:18367662-Kidney Diseases,
pubmed-meshheading:18367662-Mesangial Cells,
pubmed-meshheading:18367662-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:18367662-RNA, Messenger,
pubmed-meshheading:18367662-Rats,
pubmed-meshheading:18367662-Rats, Wistar,
pubmed-meshheading:18367662-Transforming Growth Factor beta1
|
pubmed:year |
2008
|
pubmed:articleTitle |
Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells.
|
pubmed:affiliation |
Fibrosis Research Laboratory, Division of Nephrology, University of Utah School of Medicine, Salt Lake City, UT 84108, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|